$2,700,000 of ELI LILLY AND COMPANY lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Patient protection; Pharmaceutical supply chain issues and shortages; Drug pricing, coverage, value, access and quality; Transparency; Intellectual property; Health insurance accessibility; Implementation of the "Inflation Reduction Act" (HR.5376); Prescription drug approval; Policy matters related to Artificial Intelligence in health care; One Big Beautiful Bill Act (HR.1) Intellectual property; 340B Program; Medicare & Medicaid prescription drug reimbursement pricing, coverage and value; Implementation of the "Inflation Reduction Act" (HR.5376); CMS National Coverage Determination on Alzheimer's disease; One Big Beautiful Bill Act (HR.1) Multi-lateral threats to IP and the biopharmaceutical industry; Drug importation; Prescription drug value, access and quality Pharmaceutical intellectual property issues Implementation and extension of the Tax Cuts and Jobs Act; Domestic manufacturing tax incentives; Expensing of research and development costs; Global minimum tax; Pension and retirement benefit issues; round-tripping; One Big Beautiful Bill Act (HR.1) Hospital discounts; 340B program; Prescription drug value, access, quality and compliance with Drug Quality and Safety Act Issues related to intellectual property protection and market access within current trade negotiations. Canada IP; USMCA implementation; Mexico patent linkage; Special 301; Trade talks: US-Japan, US-China, US-EU, US-UK, US-India, and US-Brazil; US Tariffs"
You can find more data on corporate lobbying on Quiver Quantitative.
LLY Congressional Stock Trading
Members of Congress have traded $LLY stock 20 times in the past 6 months. Of those trades, 7 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $LLY stock by members of Congress over the last 6 months:
- REPRESENTATIVE JONATHAN L. JACKSON has traded it 2 times. They made 1 purchase worth up to $50,000 on 04/21 and 1 sale worth up to $50,000 on 06/03.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 05/30.
- REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 3 times. They made 3 purchases worth up to $45,000 on 05/14, 05/05, 01/21 and 0 sales.
- REPRESENTATIVE JOSH GOTTHEIMER has traded it 5 times. They made 1 purchase worth up to $15,000 on 05/01 and 4 sales worth up to $60,000 on 05/13, 04/09, 03/10, 02/19.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $250,000 on 05/12.
- REPRESENTATIVE BRUCE WESTERMAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 03/03 and 1 sale worth up to $15,000 on 04/21.
- SENATOR TOMMY TUBERVILLE sold up to $50,000 on 04/15.
- REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 04/11.
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 04/08.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/07.
- SENATOR RON WYDEN has traded it 2 times. They made 1 purchase worth up to $100,000 on 01/22 and 1 sale worth up to $100,000 on 02/10.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
LLY Insider Trading Activity
LLY insiders have traded $LLY stock on the open market 57 times in the past 6 months. Of those trades, 0 have been purchases and 57 have been sales.
Here’s a breakdown of recent trading of $LLY stock by insiders over the last 6 months:
- ENDOWMENT INC LILLY has made 0 purchases and 51 sales selling 534,452 shares for an estimated $474,544,560.
- DANIEL SKOVRONSKY (EVP, CSO & Pres. LRL & LLY Imm) has made 0 purchases and 3 sales selling 5,000 shares for an estimated $4,316,064.
- DONALD A ZAKROWSKI (SVP, Finance, & CAO) has made 0 purchases and 2 sales selling 2,000 shares for an estimated $1,534,650.
- ILYA YUFFA (EVP & President, LLY Int'l) sold 1,250 shares for an estimated $936,550
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
LLY Hedge Fund Activity
We have seen 1,899 institutional investors add shares of LLY stock to their portfolio, and 1,617 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PNC FINANCIAL SERVICES GROUP, INC. added 50,002,551 shares (+97.5%) to their portfolio in Q1 2025, for an estimated $41,297,606,896
- GAMMA INVESTING LLC removed 14,848,396 shares (-99.9%) from their portfolio in Q2 2025, for an estimated $11,574,770,133
- PROFICIO CAPITAL PARTNERS LLC removed 5,183,974 shares (-99.6%) from their portfolio in Q1 2025, for an estimated $4,281,495,966
- CAPITAL RESEARCH GLOBAL INVESTORS added 4,989,952 shares (+46.4%) to their portfolio in Q1 2025, for an estimated $4,121,251,256
- VANGUARD GROUP INC added 4,975,395 shares (+6.7%) to their portfolio in Q1 2025, for an estimated $4,109,228,484
- GQG PARTNERS LLC removed 2,705,511 shares (-59.7%) from their portfolio in Q1 2025, for an estimated $2,234,508,590
- FMR LLC removed 2,066,580 shares (-6.8%) from their portfolio in Q1 2025, for an estimated $1,706,809,087
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
LLY Analyst Ratings
Wall Street analysts have issued reports on $LLY in the last several months. We have seen 8 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Guggenheim issued a "Buy" rating on 07/11/2025
- UBS issued a "Buy" rating on 05/02/2025
- HSBC issued a "Reduce" rating on 04/28/2025
- Cantor Fitzgerald issued a "Overweight" rating on 04/22/2025
- Morgan Stanley issued a "Overweight" rating on 04/09/2025
- Goldman Sachs issued a "Buy" rating on 04/08/2025
- Wells Fargo issued a "Overweight" rating on 03/05/2025
To track analyst ratings and price targets for LLY, check out Quiver Quantitative's $LLY forecast page.
LLY Price Targets
Multiple analysts have issued price targets for $LLY recently. We have seen 9 analysts offer price targets for $LLY in the last 6 months, with a median target of $1038.0.
Here are some recent targets:
- Seamus Fernandez from Guggenheim set a target price of $942.0 on 07/11/2025
- Terence Flynn from Morgan Stanley set a target price of $1135.0 on 07/10/2025
- Trung Huynh from UBS set a target price of $1050.0 on 05/02/2025
- Rajesh Kumar from HSBC set a target price of $700.0 on 04/28/2025
- Carter Gould from Cantor Fitzgerald set a target price of $975.0 on 04/22/2025
- Asad Haider from Goldman Sachs set a target price of $888.0 on 04/08/2025
- Mohit Bansal from Wells Fargo set a target price of $1100.0 on 03/05/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
